Flashpoint POV
When chemotherapy fails, immunotherapy does not respond, and targeted therapies do not apply, patients are left without a path forward. BiPER Therapeutics is developing an oral drug, selected by blood test, to treat that gap directly.
What's UpNext
The F1 Circuit of the Startup Ecosystem. Tracking founders, momentum, and signals as they emerge.
Flashpoint POV
Aquaplaning has caused accidents since the first cars drove on wet roads. Giovanni Blandina founded EasyRain in Turin to become the first company to actively restore grip, not just detect its loss.
What's UpNext
The F1 Circuit of the Startup Ecosystem. Tracking founders, momentum, and signals as they emerge.
Flashpoint POV
Every year, 60 million patients suffer anesthesia complications that current monitoring cannot anticipate. Eva Gubern and Pedro Gambús built Predictheon to change that, starting with 30 years of mathematical modelling and a proprietary patient database nobody else has.
Flashpoint POV
Abdelrahman Ghareeb dislocated his knee in 2014 and spent the next decade asking why nobody saw it coming. The Egyptian founder built SEE, an AI platform that turns any phone camera into an objective movement assessor, to give every athlete the data that only professionals have ever had.
Flashpoint POV
Hermine Bonde Jahren watched her husband's psychology clinic struggle with an ever-growing waiting list and realized the access crisis was only half the problem. She built Braive to fix what happens after you get through the door, and it now supports 100,000 patients across the Nordics.
Join our global community of founders, investors, and innovators discovering the stories, startups, and movements shaping the future.
Jess Liew spent over a decade watching consulting teams rebuild from zero on every new engagement, manually assembling data before the real work could even begin. She built Intriq to break that cycle, so advisors can skip the groundwork and get straight to the insights their clients actually need.
The F1 Circuit of the Startup Ecosystem. Tracking founders, momentum, and signals as they emerge.
Brands and retailers across Central and Eastern Europe have been handed retail media solutions that start three stages ahead of where they actually are. Jakub Spryngl and his co-founders left Procter & Gamble to build Cruxo, the platform that meets them where they are.
GITEX Africa 2026 confirmed that African tech has moved past infrastructure storytelling into deployment at scale. Sovereign digital strategies and cross-border fintech are now live products, not roadmaps.
Estonian founder Kerli Luks spent years as a doctor watching women navigate hormonal health on incomplete data. Her company Muun Health is building the first continuous hormone monitoring device.
The F1 Circuit of the Startup Ecosystem. Tracking founders, momentum, and signals as they emerge.
Pharmaceutical companies have spent decades circling African markets, unable to act without reliable data. David Chen built Kapsule to fix that, pooling health records from hospitals, pharmacies, and insurers across Africa into a single compliant platform.
Carolina Valadas used mobile money daily in West Africa before she joined Sharp Vision.. Founded by Cyril and Christophe Casanova, the Paris-based RegTech now manages €5 billion in annual flows across six jurisdictions, tripling tax revenues for the governments it serves.
After 25 years in mobile and banking technology, Finnish founder Kristian Luoma identified the real obstacle to leadership, the coordination tax consuming 40% to 70% of every manager’s week. In Parallel is built to remove it.
Shwan Lamei's co-founder proved at MIT that coordinated residential devices behave like a grid-scale battery. Emulate is the production-grade platform giving utilities real control over EVs, heat pumps, and batteries already in their customers' homes.
The F1 Circuit of the Startup Ecosystem. Tracking founders, momentum, and signals as they emerge.
Capital in this year’s CIX cohort is shifting from SaaS to hard infrastructure. Defense tech, climate systems, and regulated health ventures now define the highest-conviction bets, pointing to longer-cycle, capital-intensive builds.